DV Biomed Co., Ltd. (6539.TWO)
TWD 60.8
(-0.33%)
TWD 60.8
(-0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.53 Billion | 1.86 Billion | 1.82 Billion | 1.81 Billion | 1.93 Billion |
| Cost of Revenue | 774.07 Million | 827.29 Million | 804.95 Million | 886.25 Million | 953.25 Million |
| Gross Profit | 764.27 Million | 1.03 Billion | 1.02 Billion | 925.5 Million | 977.19 Million |
| Operating Expenses | 575.24 Million | 652.56 Million | 605.35 Million | 655.92 Million | 822.03 Million |
| Selling, General and Administrative Expenses | 577.37 Million | 639.72 Million | 592.91 Million | 623.97 Million | 709.1 Million |
| Research and Development Expenses | 12.32 Million | 12.84 Million | 12.44 Million | 31.94 Million | 104.98 Million |
| Other Expenses | - | 7.28 Million | 8.99 Million | 97.94 Million | - |
| Cost and Expenses | 1.36 Billion | 1.47 Billion | 1.41 Billion | 1.54 Billion | 1.77 Billion |
| Operating Income | 173.54 Million | 369.66 Million | 398.42 Million | 343.17 Million | 163.1 Million |
| Interest Expense | 7.04 Million | 5.21 Million | 4.45 Million | 4.77 Million | 6.82 Million |
| Income Tax Expense | 35.39 Million | 76.05 Million | 91.18 Million | 51.87 Million | 49.74 Million |
| Earnings before Tax | 188.42 Million | 365.05 Million | 395.76 Million | 336.55 Million | 149.07 Million |
| Net Income | 162.91 Million | 281.25 Million | 304.57 Million | 301.4 Million | 166.28 Million |
| Earnings Per Share Basic | 7.89 | 13.59 | 14.60 | 14.34 | 7.84 |
| Earnings Per Share Diluted | 7.89 | 13.56 | 14.57 | 14.31 | 7.83 |
| Weighted Average Shares Outstanding | 20.63 Million | 20.7 Million | 20.86 Million | 21.03 Million | 21.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.65 Million | 20.73 Million | 20.86 Million | 21.05 Million | 21.23 Million |
| Gross Margin | 0.50 | 0.56 | 0.56 | 0.51 | 0.51 |
| EBIT Margin | 0.26 | 0.30 | 0.32 | 0.29 | 0.13 |
| Profit Margin | 0.11 | 0.15 | 0.17 | 0.17 | 0.09 |
| EBITDA | 407.64 Million | 582.62 Million | 610.84 Million | 545.47 Million | 247.86 Million |
| Earnings Before Tax Margin | 0.11 | 0.20 | 0.22 | 0.19 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 124.35 Million | 124.35 Million | 1.53 Billion | 362.51 Million | 362.51 Million | 406.66 Million |
| Cost of Revenue | 28.66 Million | 28.66 Million | 774.07 Million | 188.43 Million | 188.43 Million | 198.6 Million |
| Gross Profit | 95.68 Million | 95.68 Million | 764.27 Million | 174.07 Million | 174.07 Million | 208.05 Million |
| Operating Expenses | 78.15 Million | 78.15 Million | 589.69 Million | 156.23 Million | 156.23 Million | 131.38 Million |
| Selling, General and Administrative Expenses | 78.69 Million | 78.69 Million | - | 157.57 Million | 157.57 Million | 131.62 Million |
| Research and Development Expenses | 1.49 Million | 1.49 Million | - | 2.78 Million | 2.78 Million | 3.37 Million |
| Other Expenses | - | - | 33.63 Million | - | - | - |
| Cost and Expenses | 106.82 Million | 106.82 Million | 1.36 Billion | 344.67 Million | 344.67 Million | 329.98 Million |
| Operating Income | 15.49 Million | 15.49 Million | 196.49 Million | 13.71 Million | 13.71 Million | 73.05 Million |
| Interest Expense | - | - | 7.04 Million | - | - | - |
| Income Tax Expense | 4.11 Million | 4.11 Million | 35.39 Million | 3.85 Million | 3.85 Million | 13.84 Million |
| Earnings before Tax | 18.12 Million | 18.12 Million | 188.42 Million | 17.55 Million | 17.55 Million | 76.65 Million |
| Net Income | 12.63 Million | 12.63 Million | 162.91 Million | 13.7 Million | 13.7 Million | 62.81 Million |
| Earnings Per Share Basic | 0.68 | 0.68 | - | 0.66 | 0.66 | 3.04 |
| Earnings Per Share Diluted | 0.68 | 0.68 | - | 0.66 | 0.66 | 3.04 |
| Weighted Average Shares Outstanding | 18.57 Million | 18.57 Million | 20.63 Million | 20.62 Million | 20.62 Million | 20.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.57 Million | 18.57 Million | 20.65 Million | 20.64 Million | 20.64 Million | 20.66 Million |
| Gross Margin | 0.77 | 0.77 | 0.50 | 0.48 | 0.48 | 0.51 |
| EBIT Margin | 0.17 | 0.17 | - | 0.10 | 0.10 | 0.23 |
| Profit Margin | 0.10 | 0.10 | 0.11 | 0.04 | 0.04 | 0.15 |
| EBITDA | 21.01 Million | 21.01 Million | - | 37.02 Million | 37.02 Million | 95.03 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.13 | 0.04 | 0.04 | 0.18 |
PPY
OXY
002593
OV8
1418
MEDAF